Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial
…, E Grigsby, D Grosz, K Hafner, D Hart, S Henein… - Jama, 2023 - jamanetwork.com
Importance There are limited efficacious treatments for Alzheimer disease. Objective To assess
efficacy and adverse events of donanemab, an antibody designed to clear brain amyloid …
efficacy and adverse events of donanemab, an antibody designed to clear brain amyloid …
Screening for atrial fibrillation in the older population: a randomized clinical trial
…, AP Benz, JA Wong, F Merali, S Henein… - JAMA …, 2021 - jamanetwork.com
Importance Atrial fibrillation (AF) is a major cause of preventable strokes. Screening asymptomatic
individuals for AF may increase anticoagulant use for stroke prevention. Objective To …
individuals for AF may increase anticoagulant use for stroke prevention. Objective To …
Effectiveness of a novel ω-3 krill oil agent in patients with severe hypertriglyceridemia: a randomized clinical trial
…, A Frechette, P Dzongowski, S Henein… - JAMA network …, 2022 - jamanetwork.com
Importance Intense interest exists in novel ω-3 formulations with high bioavailability to reduce
blood triglyceride (TG) levels. Objective To determine the phase 3 efficacy and safety of a …
blood triglyceride (TG) levels. Objective To determine the phase 3 efficacy and safety of a …
[HTML][HTML] Antibody persistence and booster response in adolescents and young adults 4 and 7.5 years after immunization with 4CMenB vaccine
…, F de Looze, H Marshall, P Richmond, S Henein… - Vaccine, 2019 - Elsevier
Background Data on duration of protection against invasive meningococcal disease post-vaccination
with the recombinant, 4-component, meningococcal serogroup B vaccine (4CMenB…
with the recombinant, 4-component, meningococcal serogroup B vaccine (4CMenB…
[HTML][HTML] Is screening for atrial fibrillation in Canadian family practices cost-effective in patients 65 years and older?
…, C Ramasundarahettige, PA Frydrych, S Henein… - Canadian Journal of …, 2018 - Elsevier
We present an economic evaluation of a recently completed cohort study in which 2054 seniors
were screened for atrial fibrillation (AF) in 22 Canadian family practices. Using a Markov …
were screened for atrial fibrillation (AF) in 22 Canadian family practices. Using a Markov …
Diagnostic accuracy and yield of screening tests for atrial fibrillation in the family practice setting: a multicentre cohort study
…, PA Frydrych, S Henein… - … Open Access Journal, 2018 - cmajopen.ca
Background: Detection of undiagnosed or undertreated (“actionable”) atrial fibrillation could
increase the use of appropriate oral anticoagulant therapy and reduce the risk of stroke. We …
increase the use of appropriate oral anticoagulant therapy and reduce the risk of stroke. We …
Two phase 3 trials of dupilumab versus placebo in atopic dermatitis
…, T Vlaeva, A Alavi, G Gauvreau, S Henein… - NEW ENGLAND …, 2016 - ricerca.unich.it
BACKGROUND Dupilumab, a human monoclonal antibody against interleukin-4 receptor
alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be …
alpha, inhibits signaling of interleukin-4 and interleukin-13, type 2 cytokines that may be …
152. Protective Antibody Levels 7.5 Years After Primary Vaccination in Adolescence With a Recombinant, 4-Component, Meningococcal Serogroup B Vaccine …
…, H Marshall, P Richmond, S Henein… - Open Forum …, 2018 - academic.oup.com
Background 4CMenB has been shown to be immunogenic with an acceptable safety profile
in infants and young adolescents. However, no data on long-term persistence after primary …
in infants and young adolescents. However, no data on long-term persistence after primary …
[PDF][PDF] 154. Diagnosis and Genotyping of Coxiella burnetii Causing Endocarditis in a Patient With Prosthetic Pulmonary Valve Replacement (PVR) Using Next …
M Kondo, S Dalai, L Westblade… - Open Forum …, 2018 - pdfs.semanticscholar.org
Conclusion. PCV13 was effective in preventing IPD caused by PCV13 types when excluding
type 3; no effectiveness was demonstrated against serotype 3. Disclosures. W. Schaffner, …
type 3; no effectiveness was demonstrated against serotype 3. Disclosures. W. Schaffner, …
[PDF][PDF] 153. The Effect of Timing of Tetanus–Diphtheria and Pertussis Vaccine Administration in Pregnancy on The Avidity of Pertussis Antibodies
Conclusion. PCV13 was effective in preventing IPD caused by PCV13 types when excluding
type 3; no effectiveness was demonstrated against serotype 3. Disclosures. W. Schaffner, …
type 3; no effectiveness was demonstrated against serotype 3. Disclosures. W. Schaffner, …